Rheaply
PrivateLast Round
Series B
Jun 7, 2022
Total Funding Raised
$33.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rheaply operates in Enterprise Software and is based in Chicago, Illinois. Its latest recorded funding round was a Series B round in June 2022.
Rheaply is a climate tech and software company that provides a resource exchange platform designed to help organizations manage, share, and reuse physical assets to support the circular economy.
Sector
Enterprise Software
Verticals
Circular Economy, Supply Chain Tracking, ESG Analytics, Waste Management, Facility Management
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheaply Comparables
Compare Rheaply with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Warp It | 78% | |
| Globechain | 78% | |
| CircularPlace | 77% |
For institutional investors. Book with your work email.
Rheaply Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 7, 2022 | ||||
| Grant | Dec 14, 2021 | ||||
| Series A Extension | Jun 23, 2021 | ||||
| Series A | Feb 16, 2021 | ||||
| Grant | Dec 3, 2020 | ||||
Seed | Mar 17, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rheaply Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT Solve | Series A Extension |
| Concentric Equity Partners | Seed |
| Techstars | Series B, Seed |
| M25 | Series A, Seed |
| Access Ventures | Grant |
| High Alpha | Series B, Series A |
| Salesforce Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 71% MoM, reaching 27.3K.
- Jul 24, 2026
Monthly visitors grew 57% MoM, reaching 21.7K.
For institutional investors. Book with your work email.
Rheaply Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rheaply's valuation, stock price, and market status.
Is Rheaply a public or private company?
Rheaply is a private company.
What is the current stock price of Rheaply?
Rheaply is a private company, so its shares have no public market price. Caplight tracks Rheaply's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rheaply worth (valuation)?
Valuation information for Rheaply is not publicly available.
Can I buy Rheaply stock?
Rheaply shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rheaply's last funding round?
Rheaply's most recent funding round was Series B on June 7, 2022.
Who are the main investors in Rheaply?
Key investors in Rheaply include High Alpha, Revolution LLC, Hyde Park Angels, Hyde Park Angels.
Will Rheaply IPO soon?
No public IPO plans have been announced for Rheaply.
How can I track Rheaply secondary market activity?
Caplight tracks bids, offers, and trades in Rheaply's shares on secondary markets.